Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells
Authors:
- Sarah RehbeinSRSarah Rehbein
- Anna-Lena PossmayerAPAnna-Lena Possmayer
- Süleyman BozkurtSBSüleyman Bozkurt
- Catharina LotschCLCatharina Lotsch
- Julia GerstmeierJGJulia Gerstmeier
- Michael BurgerMichael Burger
- Stefan MommaSMStefan Momma
- Claudia MaletzkiCMClaudia Maletzki
- Carl Friedrich ClassenCCCarl Friedrich Classen
- Thomas M. FreimanTFThomas M. Freiman
- Daniel DubinskiDDDaniel Dubinski
- Katrin LamszusKLKatrin Lamszus
Open Access
Abstract
Glioblastoma is the most common primary brain cancer in adults and represents one of the worst cancer diagnoses for patients. Suffering from a poor prognosis and limited treatment options, tumor recurrences are virtually inevitable. Additionally, treatment resistance is very common for this disease and worsens the prognosis. These and other factors are hypothesized to be largely due to the fact that glioblastoma cells are known to be able to obtain stem-like traits, thereby driving these phenotypes. Recently, we have shown that the in vitro and ex vivo treatment of glioblastoma stem-like cells with the hormonally active form of vitamin D3, calcitriol (1α,25(OH)2-vitamin D3) can block stemness in a subset of cell lines and reduce tumor growth. Here, we expanded our cell panel to over 40 different cultures and can show that, while half of the tested cell lines are sensitive, a quarter can be classified as high responders. Using genetic and proteomic analysis, we further determined that treatment success can be partially explained by specific polymorphism of the vitamin D3 receptor and that high responders display a proteome suggestive of blockade of stemness, as well as migratory potential.Keywords
All Related Versions
This publication has 64 references indexed in Scilit:
- Establishment and Characterization of Primary Glioblastoma Cell Lines from Fresh and Frozen Material: A Detailed ComparisonPLOS ONE, 2013
- Glioma Surgical Aspirate: A Viable Source of Tumor Tissue for Experimental ResearchCancers, 2013
- Targeting Stat3 and Smad7 to restore TGF-β cytostatic regulation of tumor cells in vitro and in vivoOncogene, 2012
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Vitamin D: MetabolismEndocrinology and Metabolism Clinics of North America, 2010
- PANTHER Pathway: An Ontology-Based Pathway Database Coupled with Data Analysis Tools2009
- Role of Vitamin D Receptor in the Antiproliferative Effects of Calcitriol in Tumor-Derived Endothelial Cells and Tumor Angiogenesis In vivoCancer Research, 2009
- Vitamin D signalling pathways in cancer: potential for anticancer therapeuticsNature Reviews Cancer, 2007
- CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular ProfilesCancer Research, 2007
- Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination StudiesPharmacological Reviews, 2006